Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma‐in‐Situ Who Received Breast‐Conserving Surgery
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Breast Cancer"
DOI: 10.1016/j.clbc.2018.04.002
Abstract: Purpose: To identify whether a certain group of breast ductal carcinoma‐in‐situ (DCIS) patients can be treated with breast‐conserving surgery (BCS) alone; to analyze the clinicopathologic features of DCIS and tamoxifen administration in patients treated with… read more here.
Keywords: risk; bcs; ductal carcinoma; breast ductal ... See more keywords
Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Experimental and molecular pathology"
DOI: 10.1016/j.yexmp.2017.02.012
Abstract: Tenascin C (TNC) is a key of extracellular matrix glycoprotein and highly express in numerous human malignancies. Herein, we attempted to clarify the clinicopathological significance of TNC as a prognostic determinant of breast ductal carcinoma.… read more here.
Keywords: ductal carcinoma; tnc; breast ductal; expression ... See more keywords
Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Cancer"
DOI: 10.1038/s41416-018-0337-x
Abstract: BackgroundExtracellular matrix (ECM) plays a crucial role in tumour behaviour. Prolyl-4-hydroxlase-A2 (P4HA2) is a key enzyme in ECM remodelling. This study aims to evaluate the prognostic significance of P4HA2 in breast ductal carcinoma in situ… read more here.
Keywords: p4ha2 expression; outcome; dcis; breast ductal ... See more keywords
Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ
Sign Up to like & getrecommendations! Published in 2021 at "BMC Medical Imaging"
DOI: 10.1186/s12880-021-00610-7
Abstract: Background The molecular biomarkers of breast ductal carcinoma in situ (DCIS) have important guiding significance for individualized precision treatment. This study was intended to explore the significance of radiomics based on ultrasound images to predict… read more here.
Keywords: mass type; dcis; molecular biomarkers; breast ductal ... See more keywords
Quantitatively characterizing the microstructural features of breast ductal carcinoma tissues in different progression stages by Mueller matrix microscope.
Sign Up to like & getrecommendations! Published in 2017 at "Biomedical optics express"
DOI: 10.1364/boe.8.003643
Abstract: Polarization imaging has been recognized as a potentially powerful technique for probing the microstructural information and optical properties of complex biological specimens. Recently, we have reported a Mueller matrix microscope by adding the polarization state… read more here.
Keywords: microscope; mueller matrix; ductal carcinoma; tissues different ... See more keywords
Plasma miR-1273g-3p acts as a potential biomarker for early Breast Ductal Cancer diagnosis.
Sign Up to like & getrecommendations! Published in 2020 at "Anais da Academia Brasileira de Ciencias"
DOI: 10.1590/0001-3765202020181203
Abstract: Circulating miRNAs presenting in plasma in a stable manner have been demonstrated their potential role as a promising biomarkers in many human diseases, such as Alzheimer's disease, melanoma and ovarian carcinoma. However, few circulating miRNAs… read more here.
Keywords: mir 1273g; breast ductal; ductal cancer; cancer ... See more keywords
Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14051303
Abstract: Simple Summary Specific drug targets for breast ductal carcinoma in situ (DCIS) remain elusive, despite increasing disease prevalence and burden to healthcare services. Estrogen receptor (ER)-negative HER2-positive DCIS, associated with the poorest patient prognosis, is… read more here.
Keywords: ductal carcinoma; carcinoma situ; situ dcis; dcis ... See more keywords
Expression pattern of p-Smad2/Smad4 as a predictor of survival in invasive breast ductal carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Oncology Letters"
DOI: 10.3892/ol.2020.11297
Abstract: The present study examined SMAD family member 4 (Smad4), SMAD family member 2 (Smad2) and phosphorylated (p-)Smad2 expression in biopsy specimens from patients with invasive breast ductal carcinoma, in order to assess their abilities as… read more here.
Keywords: carcinoma; smad2 smad4; breast ductal; expression ... See more keywords